Concepedia

Author

Pakeeza Sayyed

Roche (Switzerland)

Also Known As

P. Sayyed, Pakeeza Sayyed, Pakeeza Z. Sayyed, Pakeeza Zahra Sayyed, Sayyed, Pakeeza Z.

18

Publications

688

Citations

8

H-Index

16

Concepts

All Affiliations

Roche (Switzerland)Roche (United Kingdom)Aston UniversityKuwait UniversityUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”
PS

About

Pakeeza Sayyed is an author at Roche (Switzerland) specializing in medicine, immunology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

231

2

Health Sciences

2

2

136

3

Immunology

2

2

136

4

Natural Sciences

1

1

95

5

Molecular Biology

1

1

95

Pakeeza Sayyed

×

7

Publications

435

Citations

7

H-Index

YearCitations

Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes:<i>In Vitro</i>and<i>In Vivo</i>Studies

Alim Khan, Mustapha Benboubetra, Pakeeza Sayyed,

Journal of drug targeting

2004

135

The cellular delivery of antisense oligonucleotides and ribozymes

Marcus D. Hughes, Majad Hussain, Qamar Nawaz,

Drug Discovery Today

2001

95

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Antonio Salar, Irit Avivi, Beate Bittner,

Journal of Clinical Oncology

2014

92

Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

Sarit Assouline, Valéria Buccheri, Alain Delmer,

The Lancet Haematology

2016

44

Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

Sarit Assouline, Valéria Buccheri, Alain Delmer,

British Journal of Clinical Pharmacology

2015

38

MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

Ian Chau, Georg Martin Haag, Osama E. Rahma,

Annals of Oncology

2018

19

A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment

Antonio Salar, Réda Bouabdallah, Christine McIntyre,

Blood

2010

12

Page 1